”maximum dose” points in cervical and endometrial cancer medium dose rate brachytherapy

Authors

a. meysamie medical faculty, tehran university of medical sciences, tehran, iran

h.r. dehghan manshadi haft tir hospital, iran university of medical sciences, tehran, iran

a.a. sharafi department of radiology technology, iran university of medical sciences, tehran, iran

abstract

background: best dose distribution in target volume and control of organ at risk (oar) dose are the two main goals in brachytherapy. materials and methods: in this study in vivo dosimetry in 4 rectal points was performed by transillumination dosimeter (tld) s and the measured doses were compared in different patients. one point was reported to have the maximum dose in each patient and the very dose was considered as rectal dose according to icru-38 prescription however, the next higher dose was also considered the same as the highest point when the difference was not more than 10% of the highest value. results: in more than 50% of the cases the 1st and 2nd highest points were in the same range with less than 10% variation. there were 3 points in approximately equal dose in 7% of cases. conclusion: these findings are challenging with the icru-38 recommendations reporting the existence of a sole maximum rectal dose. so it seems wise to consider an isodose plate of maximum doses instead of one point only. iran. j. radiat. res., 2009 6 (4): 189-194

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

”Maximum dose” points in cervical and endometrial cancer medium dose rate brachytherapy

Background: Best dose distribution in target volume and control of Organ at Risk (OAR) dose are the two main goals in brachytherapy. Materials and Methods: In this study in vivo dosimetry in 4 rectal points was performed by Transillumination Dosimeter (TLD) s and the measured doses were compared in different patients. One point was reported to have the maximum dose in each patient and the very ...

full text

Low dose rate brachytherapy using a tandem for cervical cancer

PURPOSE To report the results of the Instituto Nacional de Cancerología México, of low dose rate brachytherapy for cervical cancer using only a tandem. A proportion of patients was treated with only a tandem, without ovoids, due to the distorted anatomy because of the tumour or previous external radiation, or sometimes due to physician preference. MATERIAL AND METHODS We report the results of...

full text

Treatment planning for high dose rate brachytherapy of cervical cancer based on total dose constraints.

OBJECTIVE To compare the inverse planning optimization based on total dose constraints versus conventional treatment plan (point A planning method) for cervical carcinoma, and evaluate the benefit of CT-based image-guided brachytherapy. METHODS We prospectively analyzed data of 10 consecutive patients with cervical cancer treated with external beam radiotherapy to the whole pelvis (45 Gy in 2...

full text

High dose rate brachytherapy for prostate cancer.

High dose rate (HDR) afterloading brachytherapy in the management of localised prostate cancer has practical, physical and biological advantages over low dose rate seed brachytherapy. There are no free live sources used, no risk of source loss and since the implant is a temporary procedure following discharge no issues with regard to radioprotection use of existing facilities. Adequate coverage...

full text

High dose rate brachytherapy for oral cancer

Brachytherapy results in better dose distribution compared with other treatments because of steep dose reduction in the surrounding normal tissues. Excellent local control rates and acceptable side effects have been demonstrated with brachytherapy as a sole treatment modality, a postoperative method, and a method of reirradiation. Low-dose-rate (LDR) brachytherapy has been employed worldwide fo...

full text

Pulsed dose rate brachytherapy of lip cancer

PURPOSE PURPOSE To present our experience with pulsed dose rate brachytherapy (PDR BT) of lip cancer. MATERIAL AND METHODS The study group included 32 T1-4N0M0 lip cancer patients with a median age of 71 years (ranged 41-87 years), treated with interstitial PDR BT to the planned total dose of 60-70 Gy; 1 Gy/pulse, pulses repeated every hour a day. There were 26 untreated patients, and six ...

full text

My Resources

Save resource for easier access later


Journal title:
iranian journal of radiation research

جلد ۶، شماره ۴، صفحات ۱۸۹-۱۹۴

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023